APA (7th ed.) Citation

Umeyama, T., Hayashi, Y., Shimosaka, H., Inukai, T., Yamagoe, S., Takatsuka, S., . . . Miyazaki, Y. (2018). CRISPR/Cas9 Genome Editing To Demonstrate the Contribution of Cyp51A Gly138Ser to Azole Resistance in Aspergillus fumigatus. Antimicrobial agents and chemotherapy, 62(9), . https://doi.org/10.1128/AAC.00894-18

Chicago Style (17th ed.) Citation

Umeyama, Takashi, et al. "CRISPR/Cas9 Genome Editing To Demonstrate the Contribution of Cyp51A Gly138Ser to Azole Resistance in Aspergillus Fumigatus." Antimicrobial Agents and Chemotherapy 62, no. 9 (2018). https://doi.org/10.1128/AAC.00894-18.

MLA (9th ed.) Citation

Umeyama, Takashi, et al. "CRISPR/Cas9 Genome Editing To Demonstrate the Contribution of Cyp51A Gly138Ser to Azole Resistance in Aspergillus Fumigatus." Antimicrobial Agents and Chemotherapy, vol. 62, no. 9, 2018, https://doi.org/10.1128/AAC.00894-18.